September 27, 2016 6:08 AM ET


Company Overview of Aridis Pharmaceuticals Inc.

Company Overview

Aridis Pharmaceuticals Inc., a biopharmaceutical company, develops anti-infective product candidates. The company offers AR-301, an anti-Staphylococcus aureus human monoclonal antibody to treat acute pneumonia; AR-101 and AR-104 that are specific lgM monoclonal antibodies, which target pseudomonas aeruginosa; and Aerucin, a broadly reactive monoclonal antibody against Pseudomonas aeruginosa. It also provides Panaecin, a small molecule anti-infective gallium compound with broad spectrum activities against bacteria, viruses, and fungi; AR201, a human monoclonal antibody, which treats respiratory syncytial virus infections; and AR401, a human monoclonal antibody for the treatment of Nosocomial ...

5941 Optical Court

San Jose, CA 95138

United States

Founded in 2005





Key Executives for Aridis Pharmaceuticals Inc.

Founder, Chief Executive Officer, and Director
Chairman of the Board and President
Chief Financial Officer
Age: 65
Chief Medical Officer
Acting General Counsel
Age: 53
Compensation as of Fiscal Year 2016.

Aridis Pharmaceuticals Inc. Key Developments

Aridis Pharmaceuticals Inc. Announces Appointments to Clinical Advisory Board

Aridis Pharmaceuticals Inc. announced the addition of three highly recognized experts, Bruno Francois, M.D., Jean Chastre, M.D., and Marin Kollef, M.D., F.A.C.P., F.C.C.P., to the company's Clinical Advisory Board. These world-renowned authorities in hospital-acquired and ventilator-associated pneumonia (HAP and VAP) and infectious disease in the intensive care medicine (ICU) setting are bringing their experience and knowledge to help drive Aridis' leading edge clinical programs forward. Dr. Francois, a specialist in intensive care medicine and anesthesiology, heads the Limoges Clinical Investigation Center with a specific focus on infectious diseases in critically ill patients at the University Hospital of Limoges, France. Dr. Chastre, Consulting Professor in the Medical ICU and former director of the same ICU at Institut de Cardiologie, Groupe Hospitalier Piti -Salptri re in Paris, France, also served as a member of the Clinical Advisory Board at Kenta Biotech AG. Dr. Kollef is the director of the medical intensive care unit and respiratory care services at Barnes-Jewish Hospital in St. Louis, Missouri.

Aridis Pharmaceuticals Appoints Robert Ruffolo to its Board of Directors

Aridis Pharmaceuticals Inc. announced that it has appointed a pharmaceutical executive Robert Ruffolo, Jr., Ph.D., D.Sc.(h), D.Eng.(h), F.C.P.P., to its Board of Directors. Dr. Ruffolo is the retired President of Research and Development at Wyeth Pharmaceuticals (now Pfizer), and retired Corporate Senior Vice President of Wyeth. He has also held senior leadership roles at SmithKline Beecham (now GlaxoSmithKline) and Lilly Research Laboratories. Dr. Ruffolo brings substantial drug discovery and development expertise to Aridis. At Wyeth, Dr. Ruffolo managed an R&D organization of 9,000 scientists with an annual budget in excess of $3 billion. Prior to Wyeth, Dr. Ruffolo spent 17 years at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) where he was Senior Vice President and Director of Biological Sciences, Worldwide.

Aridis Pharmaceuticals Inc. Presents at 18th Annual BIO CEO & Investor Conference 2016, Feb-08-2016 08:45 AM

Aridis Pharmaceuticals Inc. Presents at 18th Annual BIO CEO & Investor Conference 2016, Feb-08-2016 08:45 AM. Venue: The Waldorf Astoria, 301 Park Avenue, New York, New York, United States. Speakers: Vu L. Truong, Founder, Chief Executive Officer, and Director.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Private Placement
August 12, 2016
Private Placement
November 4, 2015

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aridis Pharmaceuticals Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at